Perceptive Advisors’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.7M | Sell |
|
|||||
|
2025
Q1 | $27.2M | Buy |
|
|||||
|
2024
Q4 | $15.3M | Sell |
|
|||||
|
2024
Q3 | $21.2M | Sell |
|
|||||
|
2024
Q2 | $31M | Sell |
|
|||||
|
2024
Q1 | $42.5M | Hold |
|
|||||
|
2023
Q4 | $29.1M | Sell |
|
|||||
|
2023
Q3 | $25M | Sell |
|
|||||
|
2023
Q2 | $43.9M | Hold |
|
|||||
|
2023
Q1 | $39.4M | Hold |
|
|||||
|
2022
Q4 | $46.2M | Buy |
|
|||||
|
2022
Q3 | $26.6M | Sell |
|
|||||
|
2022
Q2 | $22.8M | Sell |
|
|||||
|
2022
Q1 | $21.8M | Hold |
|
|||||
|
2021
Q4 | $16.8M | Sell |
|
|||||
|
2021
Q3 | $15M | Sell |
|
|||||
|
2021
Q2 | $26.5M | Hold |
|
|||||
|
2021
Q1 | $29.2M | Hold |
|
|||||
|
2020
Q4 | $32.3M | Hold |
|
|||||
|
2020
Q3 | $39.6M | Hold |
|
|||||
|
2020
Q2 | $48.6M | Hold |
|
|||||
|
2020
Q1 | $47.8M | Buy |
|
|||||
|
2019
Q4 | $46.1M | Hold |
|
|||||
|
2019
Q3 | $51.3M | Hold |
|
|||||
|
2019
Q2 | $44.6M | Buy |
|
|||||
|
2019
Q1 | $24.7M | Hold |
|
|||||
|
2018
Q4 | $14.5M | Hold |
|
|||||
|
2018
Q3 | $40.5M | Hold |
|
|||||
|
2018
Q2 | $29.4M | Buy |
|
|||||
|
2018
Q1 | $17.6M | Hold |
|
|||||
|
2017
Q4 | $12.3M | Buy |
|
|||||
|
2017
Q3 | $2.22M | Hold |
|
|||||
|
2017
Q2 | $2.77M | Hold |
|
|||||
|
2017
Q1 | $3.52M | Hold |
|
|||||
|
2016
Q4 | $3.69M | Sell |
|
|||||
|
2016
Q3 | $5.33M | Buy |
|